Product Information
DAYTRANA 15 MG/9 HR PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $5.7439 per EA under NDC 68968555303. Its NADAC has been published 652 times since Nov 28, 2013.
FDA first approved this application on Apr 6, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/9h
Manufacturer
Noven Therapeutics, LLCNDC
68968555303
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
3/18/2026
Active Ingredients
METHYLPHENIDATEApproval Type
New Drug (NDA)
FDA Application
NDA021514FDA Approved
4/6/2006
TE Code
AB
On Market Since
4/6/2006
Pharmacological Classes
Price Statistics
The NADAC for DAYTRANA 15 MG/9 HR PATCH has been published 652 times since Nov 28, 2013, and over the history we have for it it has declined 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7439 per EA |
|---|---|
| All-time high | $14.8025 (Nov 22, 2023) |
| All-time low | $5.7374 (Jun 19, 2024) |
| 52-week high | $5.7522 |
| 52-week low | $5.7439 |
| Median price | $9.7181 |
| Average price | $10.1161 |
| Largest weekly change | -61.0% (Nov 29, 2023) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
-0.1%
3Y
-61.2%
5Y
-57.1%
All
-15.5%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the methylphenidate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Noven Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylphenidate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DAYTRANA 15 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for DAYTRANA 15 MG/9 HR PATCH, manufactured by Noven Therapeutics, LLC, is $5.7439 per EA (NDC 68968555303), effective May 20, 2026.
How has the price of DAYTRANA 15 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for DAYTRANA 15 MG/9 HR PATCH has declined 15.5%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DAYTRANA 15 MG/9 HR PATCH?
Since Nov 28, 2013, the NADAC for DAYTRANA 15 MG/9 HR PATCH has ranged from a low of $5.7374 (Jun 19, 2024) to a high of $14.8025 (Nov 22, 2023), with a median of $9.7181 per EA.
Are there cheaper alternatives to DAYTRANA 15 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of DAYTRANA 15 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DAYTRANA 15 MG/9 HR PATCH?
DAYTRANA 15 MG/9 HR PATCH (NDC 68968555303) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.